ACH (Accendra Health, Inc.) Stock Analysis - AI Report

Accendra Health, Inc. (ACH) is a publicly traded the market company. As of May 21, 2026, ACH trades at $2.67 with a market cap of $209.84M and a P/E ratio of 0.00. ACH moved -4.64% today. Year to date, ACH is +34.85%; over the trailing twelve months it is flat. Its 52-week range spans $1.84 to $4.69. Analyst consensus is neutral with an average price target of $4.44. Rallies surfaces ACH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on ACH?

Rallies AI research for ACH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

ACH Key Metrics

Key financial metrics for ACH
MetricValue
Price$2.67
Market Cap$209.84M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.12%
52-Week High$4.69
52-Week Low$1.84
Volume8
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ACH News

ACH Analyst Consensus

4 analysts cover ACH: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.44.

Common questions about ACH

What is the AI research view on ACH?
Rallies AI research for ACH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ACH?
Rallies AI research for ACH combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ACH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACH. It does not provide personalized investment advice.
ACH

ACH